In MS, there is dysregulation in growth factors (PDGF-AA, TGF-a, and EGF) and chemokines (MCP-1/CCL2, MIP-1b/CCL4, MDC/CCL22, and IL-8/CXCL8). Here, CCL22 is linked to myeloid sarcoma.